Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomer M Mark

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Current Hematologic Malignancy Reports|August 23, 2014
Controversies in multiple myeloma: to transplant or not?Isabel Ruth Preeshagul, Koen Van Besien, Tomer M Mark
Pulmonary Circulation|September 25, 2015
Pulmonary hypertension complicating multiple myelomaUdhay Krishnan, Tomer M Mark, Ruben Niesvizky, et al.
Critical Reviews in Oncology/Hematology|June 22, 2013
Pomalidomide: new immunomodulatory agent with potent antiproliferative effectsPaul G Richardson, Tomer M Mark, Martha Q Lacy
Current Hematologic Malignancy Reports|February 23, 2016
Practical Approaches to the Management of Dual Refractory Multiple MyelomaHans C Lee, Tomer M Mark, Jatin J Shah
Clinical Case Reports|October 3, 2022
Lenalidomide-induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosisStephanie Lakritz, Peter A Forsberg, Daniel W Sherbenou, et al.
Frontiers in Immunology|November 13, 2023
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitorsAdam F Binder, Christopher J Walker, Tomer M Mark, et al.
Frontiers in Oncology|July 11, 2022
Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic ParadigmAlana L Keller, Daniel W Sherbenou, Peter A Forsberg, et al.
Frontiers in Oncology|October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacyMuhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Case Reports in Oncological Medicine|November 21, 2015
Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of LiteratureAleksey Novikov, Horatio Holzer, Robert A DeSimone, et al.
Leukemia & Lymphoma|January 12, 2019
Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myelomaPeter A Forsberg, Andrew Hammes, Diana Abbott, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|August 23, 2014
Controversies in multiple myeloma: to transplant or not?Isabel Ruth Preeshagul, Koen Van Besien, Tomer M Mark
Pulmonary Circulation|September 25, 2015
Pulmonary hypertension complicating multiple myelomaUdhay Krishnan, Tomer M Mark, Ruben Niesvizky, et al.
Critical Reviews in Oncology/Hematology|June 22, 2013
Pomalidomide: new immunomodulatory agent with potent antiproliferative effectsPaul G Richardson, Tomer M Mark, Martha Q Lacy
Current Hematologic Malignancy Reports|February 23, 2016
Practical Approaches to the Management of Dual Refractory Multiple MyelomaHans C Lee, Tomer M Mark, Jatin J Shah
Clinical Case Reports|October 3, 2022
Lenalidomide-induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosisStephanie Lakritz, Peter A Forsberg, Daniel W Sherbenou, et al.
Frontiers in Immunology|November 13, 2023
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitorsAdam F Binder, Christopher J Walker, Tomer M Mark, et al.
Frontiers in Oncology|July 11, 2022
Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic ParadigmAlana L Keller, Daniel W Sherbenou, Peter A Forsberg, et al.
Frontiers in Oncology|October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacyMuhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Case Reports in Oncological Medicine|November 21, 2015
Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of LiteratureAleksey Novikov, Horatio Holzer, Robert A DeSimone, et al.
Leukemia & Lymphoma|January 12, 2019
Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myelomaPeter A Forsberg, Andrew Hammes, Diana Abbott, et al.
Pageof 5